AbCellera Biologics Inc.NASDAQ: ABCL

AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026

· Issued by AbCellera Biologics Inc. via Business Wire

Summary by 6ix AI

AbCellera, a clinical-stage biotechnology company that develops antibody-based medicines, will report its second quarter 2026 financial results on Wednesday, August 5, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

Key details

  • A live audio webcast of the call will be available through a link to be posted on AbCellera's Investor Relations website, with a replay available through the same link after the call.

6ix AI wrote this summary from the release below and checked it against the release.

AbCellera (Nasdaq: ABCL) will announce its second quarter 2026 financial results on Wednesday, August 5, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women’s health, immunology, oncology, and more. For more information, please visit www.abcellera.com.

View original source (Business Wire)AbCellera Biologics Inc. on 6ix

Story so far

Earlier from AbCellera Biologics

Later from AbCellera Biologics

All AbCellera Biologics news releases